NCT01767272

Dose Proportionality of Fexofenadine in Healthy Human Egyptian Volunteers

Dose Proportionality of Fexofenadine

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 25 (actual)
• Sponsor: Damanhour University · Academic / Other
• Sex: Male
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The present study was adopted to evaluate the pharmacokinetics and dose linearity of fexofenadine after oral administration.

Detailed description

The present study was adopted to evaluate the pharmacokinetics and dose linearity of fexofenadine after administration of single oral doses of 60 to 360 mg in an open-label, five-way crossover study.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	fexofenadine	fexofenadine brand name

Timeline

• Start date: 2012-12-01
• Primary completion: 2013-01-01
• Completion: 2013-01-01
• First posted: 2013-01-14
• Last updated: 2013-01-14